Literature DB >> 6727565

[125I] 3-quinuclidinyl 4-iodobenzilate: a high affinity, high specific activity radioligand for the M1 and M2-acetylcholine receptors.

R E Gibson, W J Rzeszotarski, E M Jagoda, B E Francis, R C Reba, W C Eckelman.   

Abstract

We have prepared a radioiodinated ligand which binds with high affinity to the muscarinic acetylcholine receptor (m-AChR). A derivative of 3-quinuclidinyl benzilate, [125I] labeled (R) 1-aza-bicyclo(2.2.2)oct-3-yl (R,S)-alpha-hydroxy-alpha-(4-[125I]iodophenyl)phenyl acetate (4- IQNB ) exhibits an affinity for the m-AChR from corpus striatum higher than that of (R) [3H] QNB. Additionally, [125I] 4- IQNB exhibits receptor selectivity for the M1 receptor since the affinity for the receptor from dog and rat heart is lower than that using dog or rat corpus striatum.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6727565     DOI: 10.1016/0024-3205(84)90219-4

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  3 in total

Review 1.  Tracers for metabolic imaging of brain and heart. Radiochemistry and radiopharmacology.

Authors:  G Stöcklin
Journal:  Eur J Nucl Med       Date:  1992

2.  Deficits in iodine-labelled 3-quinuclidinyl benzilate binding in relation to cerebral blood flow in patients with Alzheimer's disease.

Authors:  D J Wyper; D Brown; J Patterson; J Owens; R Hunter; E Teasdale; J McCulloch
Journal:  Eur J Nucl Med       Date:  1993-05

Review 3.  Landscape of Myeloid-derived Suppressor Cell in Tumor Immunotherapy.

Authors:  Zhaonian Hao; Ruyuan Li; Yuanyuan Wang; Shuangying Li; Zhenya Hong; Zhiqiang Han
Journal:  Biomark Res       Date:  2021-10-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.